Stay updated on Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page
- Check2 days agoChange DetectedA new version entry (v3.5.5) was added on 2026-06-04, introducing updated Study Status and Contacts/Locations sections; the previous revision (v3.5.4) was removed on 2026-04-14.SummaryDifference0.4%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision label v3.5.4 appears in the record history, replacing the previous v3.5.3. This reflects an internal update to the page rendering rather than any change to trial data or user-facing content.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2 on the page, indicating a new build of the ClinicalTrials.gov history view. This update is a metadata/version change and does not alter study data, records, or user-facing functionality.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded Contacts/Locations and Study Status sections in the version history, updating the record with current recruitment status and location details. The revision is v3.5.2.SummaryDifference0.4%

- Check74 days agoChange DetectedAdded Revision: v3.5.0 to the history and removed Revision: v3.4.3.SummaryDifference0.1%

- Check88 days agoChange DetectedA new revision entry (v3.4.3) was added to the history, replacing the previous entry (v3.4.2).SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.